Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in...

por Zeng, Yan-Ming, Xu, Xiao-Lei, He, Xiao-Qing, Tang, Sheng-Quan, Li, Yao, Huang, Yin-Qiu, Harypursat, Vijay, Chen, Yao-Kai
Publicado 2020

Pretreatment drug resistance in people living with HIV: A large retrospective cohort study in Chongqing, China

por Liu, Min, He, Xiao‐Qing, Deng, Ren‐Ni, Tang, Sheng‐Quan, Harypursat, Vijay, Lu, Yan‐Qiu, He, Kun, Huo, Qin, Yang, Hong‐Hong, Liu, Qian, Chen, Yao‐Kai
Publicado 2022

Timing of antiretroviral therapy for HIV-infected patients with cytomegalovirus retinitis: study protocol of a multi-center prospective randomized controlled trial

por He, Xiao-Qing, Huang, Yin-Qiu, Zeng, Yan-Ming, Qin, Yuan-Yuan, Tang, Sheng-Quan, Xu, Xiao-Lei, Harypursat, Vijay, Lu, Yan-Qiu, Liu, Min, Yuan, Jing, Chen, Yao-Kai
Publicado 2021

No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopina...

por Huang, Yin-Qiu, Tang, Sheng-Quan, Xu, Xiao-Lei, Zeng, Yan-Ming, He, Xiao-Qing, Li, Yao, Harypursat, Vijay, Lu, Yan-Qiu, Wan, Yan, Zhang, Lu, Sun, Qiang-Zhong, Sun, Nan-Nan, Wang, Gui-Xue, Yang, Zhong-Ping, Chen, Yao-Kai
Publicado 2020